Comment
|
Open Access
Featured
-
-
Article
| Open AccessIntratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer
- Taichi Kuwahara
- , Shoichi Hazama
- & Hiroaki Nagano
-
Article
| Open AccessAcidity promotes tumour progression by altering macrophage phenotype in prostate cancer
- Asmaa El-Kenawi
- , Chandler Gatenbee
- & Robert Gillies
-
Article
| Open AccessTumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
- Mark A. Glaire
- , Enric Domingo
- & David N. Church
-
Article
| Open AccessHigh endothelial venules are associated with microsatellite instability, hereditary background and immune evasion in colorectal cancer
- Pauline L. Pfuderer
- , Alexej Ballhausen
- & Aysel Ahadova
-
Article
| Open AccessDistinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer
- Caroline Laheurte
- , Magalie Dosset
- & Olivier Adotévi
-
Article
| Open AccessImmune recurrence score using 7 immunoregulatory protein expressions can predict recurrence in stage I–III breast cancer patients
- Dae-Won Lee
- , Han Suk Ryu
- & Seock-Ah Im
-
Brief Communication
| Open AccessClinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study
- David J. Pinato
- , Francesco A. Mauri
- & Rohini Sharma
-
Review Article
| Open AccessHarnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
- Jakob Nikolas Kather
- & Niels Halama
-
Brief Communication
| Open AccessRevisiting immune escape in colorectal cancer in the era of immunotherapy
- Marieke Erica Ijsselsteijn
- , Florent Petitprez
- & Noel Filipe da Cunha Carvalho de Miranda
-
Article
| Open AccessMitochondrial DNA in the tumour microenvironment activates neutrophils and is associated with worse outcomes in patients with advanced epithelial ovarian cancer
- Kelly L. Singel
- , Kassondra S. Grzankowski
- & Brahm H. Segal
-
Article
| Open AccessEarly immune modulation by single-agent trastuzumab as a marker of trastuzumab benefit
- Tiziana Triulzi
- , Viola Regondi
- & Elda Tagliabue
-
Article
| Open AccessHigh-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy
- Felicitas Rataj
- , Severin J. Jacobi
- & Sebastian Kobold
-
Review Article
| Open AccessCytokines in clinical cancer immunotherapy
- Pedro Berraondo
- , Miguel F. Sanmamed
- & Ignacio Melero
-
Review Article
| Open AccessImmunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
- Christopher Groth
- , Xiaoying Hu
- & Viktor Umansky
-
Article
| Open AccessImmune dysregulation in cancer patients developing immune-related adverse events
- Shaheen Khan
- , Saad A. Khan
- & David E. Gerber
-
Article
| Open AccessMismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma
- Benjamin Goeppert
- , Stephanie Roessler
- & Matthias Kloor
-
Article
| Open AccessCombinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer
- Viswanath Gunda
- , Benjamin Gigliotti
- & Sareh Parangi
-
Article
| Open AccessA prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers
- Claudia J. C. Meurs
- , Joost van Rosmalen
- & Pieter J. Westenend
-
Correspondence |
Comment on “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
- Burak Uzunparmak
- & Ibrahim H. Sahin
-
Article
| Open AccessSerially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel
- Alina V. Brenner
- , Peter D. Inskip
- & Ruth M. Pfeiffer
-
-
Article
| Open AccessSystemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
- Erta Kalanxhi
- , Sebastian Meltzer
- & Anne Hansen Ree
-
Clinical Study
| Open AccessDevelopment of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials
- Shiraj Sen
- , Kenneth Hess
- & Vivek Subbiah
-
Translational Therapeutics
| Open AccessA novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
- Hyun-Il Cho
- , Un-Hee Kim
- & Tai-Gyu Kim
-
Molecular Diagnostics
| Open AccessNeutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
- Jane Margetts
- , Laura F Ogle
- & Helen L Reeves
-
Translational Therapeutics
| Open AccessInterferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response
- Mu-qing Yang
- , Qiang Du
- & David A Geller
-
Clinical Study
| Open AccessIntratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
- An Na Seo
- , Byung Woog Kang
- & Jong Gwang Kim
-
Mini Review
| Open AccessTAMeless traitors: macrophages in cancer progression and metastasis
- Shweta Aras
- & M Raza Zaidi
-
Clinical Study
| Open AccessSuccessful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy
- Rebecca Y Tay
- , Elizabeth Blackley
- & Andrew Haydon
-
Clinical Study
| Open AccessIntegrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma
- A J Zurita
- , R C Gagnon
- & J V Heymach
-
Molecular Diagnostics
| Open AccessCD47 overexpression is associated with decreased neutrophil apoptosis/phagocytosis and poor prognosis in non-small-cell lung cancer patients
- Lourdes Barrera
- , Edgar Montes-Servín
- & Oscar Arrieta
-
Molecular Diagnostics
| Open AccessMHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue
- Hormas Ghadially
- , Lee Brown
- & Robert W Wilkinson
-
Epidemiology
| Open AccessHistory of chronic inflammatory disorders increases the risk of Merkel cell carcinoma, but does not correlate with Merkel cell polyomavirus infection
- Helka Sahi
- , Harri Sihto
- & Eero Pukkala
-
Molecular Diagnostics
| Open AccessIncreased micronucleus frequency in peripheral blood lymphocytes predicts the risk of bladder cancer
- Barbara Pardini
- , Clara Viberti
- & Giuseppe Matullo
-
Molecular Diagnostics
| Open AccessCritical evaluation of the potential prognostic value of the pretreatment-derived neutrophil–lymphocyte ratio under consideration of C-reactive protein levels in clear cell renal cell carcinoma
- Orietta Dalpiaz
- , Theresa Luef
- & Martin Pichler
-
Molecular Diagnostics
| Open AccessA protein fragment derived from DNA-topoisomerase I as a novel tumour-associated antigen for the detection of early stage carcinoma
- Shang-mian Yie
- , Shang-rong Ye
- & Jie Zeng
-
Translational Therapeutics
| Open AccessIL-6 controls resistance to radiation by suppressing oxidative stress via the Nrf2-antioxidant pathway in oral squamous cell carcinoma
- Yuichiro Matsuoka
- , Hideki Nakayama
- & Ryuji Murakami
-
Clinical Study
| Open AccessAxillary lymph node micrometastases decrease triple-negative early breast cancer survival
- G Houvenaeghel
- , R Sabatier
- & E Lambaudie
-
Molecular Diagnostics
| Open AccessImpact of non-neoplastic vs intratumoural hepatitis B viral DNA and replication on hepatocellular carcinoma recurrence
- Qin Wang
- , Luan Lin
- & Spiros P Hiotis
-
Translational Therapeutics
| Open AccessCXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer
- Holger Bronger
- , Judith Singer
- & Stefanie Avril
-
Translational Therapeutics
| Open AccessTumour and immune cell dynamics explain the PSA bounce after prostate cancer brachytherapy
- Yoichiro Yamamoto
- , Chetan P Offord
- & David Dingli
-
Molecular Diagnostics
| Open AccessCharacterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers
- Jung Ho Kim
- , Hye Eun Park
- & Gyeong Hoon Kang
-
-
Short Communication
| Open AccessImpact of partial bivalent HPV vaccination on vaccine-type infection: a population-based analysis
- K Cuschieri
- , K Kavanagh
- & K G Pollock
-
Epidemiology
| Open AccessAssociation between dietary inflammatory potential and breast cancer incidence and death: results from the Women’s Health Initiative
- Fred K Tabung
- , Susan E Steck
- & James R Hébert
-
Translational Therapeutics
| Open AccessOverexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
- Yi-Peng Fu
- , Yong Yi
- & Shuang-Jian Qiu
-
Molecular Diagnostics
| Open AccessIdentification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia
- Claudia A Penafuerte
- , Bruno Gagnon
- & Michel L Tremblay
-
Molecular Diagnostics
| Open AccessMimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation
- Ans Rombout
- , Sofie Lust
- & Jan Philippé
-
Translational Therapeutics
| Open AccessHuman papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
- A Handisurya
- , C Schellenbacher
- & R Kirnbauer
Browse broader subjects
Browse narrower subjects
- Adaptive immunity
- Antigen processing and presentation
- Antimicrobial responses
- Applied immunology
- Autoimmunity
- Bone marrow transplantation
- Cell death and immune response
- Chemokines
- Coagulation system
- Complement cascade
- Cytokines
- Gene regulation in immune cells
- Haematopoiesis
- Imaging the immune system
- Immune cell death
- Immune evasion
- Immunogenetics
- Immunological disorders
- Immunotherapy
- Infection
- Infectious diseases
- Inflammation
- Innate immune cells
- Innate immunity
- Lymphatic system
- Lymphocytes
- Lymphoid tissues
- Mucosal immunology
- Neuroimmunology
- Osteoimmunology
- Plant immunology
- Signal transduction
- Translational immunology
- Transplant immunology
- Tumour immunology
- Vaccines